Experiment 896179

Worktypes

PHARMACOLOGY OF COMPOUND - IN VIVO

Compounds isolated

STAUROSPORINE

Details

PropertyValue
Pharmacology
ANTIINFLAMMATORY ACTIVITY
Administration routeEXTERNAL
OrganismEmpty organism
CitationYAMAMOTO,S: KIYOTO,I: AIZU,E: NAKADATE,T: HOSODA,Y: KATO,R:. (1989). DIFFERENTIAL INHIBITION BY STAUROSPORINE, A POTENT PROTEIN KINASE C INHIBITOR, OF 12-O-TETRADECANOYLPHORBOL-13-ACETATE-CAUSED SKIN TUMOR PROMOTION, EPIDERMAL ORNITHINE DECARBOXYLASE INDUCTION, HYPERPLASIA AND INFLAMMATION.. 10(7)
Amount utilized
Compound isolated
DiseaseVS.TPA-INDUCED SKIN INFLAMMATION.
Dose amount20.0 NANOMOLS
Number2
Qualitative resultINACTIVE
AnimalMOUSE
Per unitEAR
Dose expressionCONC USED